Search
for
Sort by
Research 181–210 of 1000+
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- Differential impact of environmental factors on systemic and localized autoimmunity
- Telecommunication in the COVID-19 era: As an assessment tool for patients with dermatomyositis
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- Beyond “Ethnicity” in Dermatology
- Hair and Nail Manifestations of Systemic Disease
- Alopecia in lupus: Experience from a tertiary referral centre
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Advances in dermatology research: A comprehensive literature review
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- A 25-year-old female with a variable presentation of MCTD-A case report
- Ritlecitinib in severe alopecia areata: a profile of its use
- SUPLEMENTAÇÃO DE VITAMINA D E SEUS IMPACTOS NA ESTÉTICA
- Patient prioritisation of impact items to develop the patient‐reported impact of dermatological diseases (PRIDD) measure: European Delphi data
- LO-010 Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus
- Cardiovascular risk in patients with selected cutaneous diseases
- Análise comparativa de 126 pacientes com lúpus discoide: perfil clínico e imunológico dos pacientes com lesões no couro cabeludo
- Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
- EXPERIENCE WITH ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH NEUROLOGICAL MANIFESTATIONS
- USE OF UPADACITINIB IN 2 CASES OF REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
- Combination of Western Medicine and Traditional Chinese Medicine for Treatment of Malignant Bone and Soft Tissue Tumors
- Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report
- Delayed treatment leading to multisystem complications in a child with SLE
- Systemic Lupus Erytomatosa in Pregnancy Accompained by Angioedema
- IMPORTANCE OF SEQUENTIAL FOLLOW-UP OF AUTOANTIBODIES IN ANA-POSITIVE PATIENTS WITH DIFFUSE HAIR LOSS
- Generalized maculopapular rash and fever
- EFFICACY OF PLATELET RICH PLASMA AS MONOTHERAPY IN TREATMENT OF ALOPECIA AREATA.
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT